Symptom Occurrence, Symptom Intensity, and Symptom Distress in Patients Undergoing High-dose Chemotherapy with Stem-cell Transplantation

Cancer Nursing

Volumn 27, Issue 1, 2004, Pages 55-64

  Larsen, Joacim ^a,b   Nordström, Gun ^a   Ljungman, Per ^a   Gardulf, Ann ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Leukemia; Multiple myeloma; Nursing; Stem cell transplantation; Symptom distress; Symptom occurrence

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN; THIOTEPA;

ACUTE LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CHRONIC LEUKEMIA; CLINICAL ARTICLE; DIARRHEA; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG MEGADOSE; FATIGUE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MULTIPLE MYELOMA; NAUSEA; PATIENT CARE; PRIORITY JOURNAL; SLEEP DISORDER; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; TASTE DISORDER; XEROSTOMIA;

EID: 0742269926     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200401000-00007     Document Type: Article

References (36)

1. Bakitas WM, Wujcik D, ed. Blood and Marrow Stem-Cell Transplantation. Indications, Procedure, Process. 2nd ed. Sudbury: Jones & Bartlett Publishers; 1997.
2. Ersek M. The process of maintaining hope in adults undergoing bone marrow transplantation for leukemia. Oncol Nurs Forum. 1992;19(6): 883-889.
3. Cohen MZ, Ley CD. Bone marrow transplantation: the battle for hope in the face of fear. Oncol Nurs Forum. 2000;27(3):473-480.
4. Gaston-Johansson F, Franco T, Zimmerman L. Pain and psychological distress in patients undergoing autologous bone marrow transplantation. Oncol Nurs Forum. 1992;19(1):41-48.
5. McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum. 1993;20(10):1493-1502.
6. Hann DM, Garovoy N, Finkelstein B, Jacobsen PB, Azzarello LM, Fields KK. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: a longitudinal comparative study. J Pain Symptom Management. 1999;17(5):311-319.
7. Kornblau S, Benson AB, Catalano R, et al. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies. J Pain Symptom Management. 2000;19(2):118-129.
8. Schulz-Kindermann F, Hennings U, Ramm G, Zander AR, Hasenbring M. The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT. Bone Marrow Transplant. 2002;29:341-351.
9. Gaston-Johansson F, Foxall M. Psychological correlates of quality of life across the autologous bone marrow transplant experience. Cancer Nurs. 1996;19(3):170-176.
10. Grassi L, Rosti G, Albertazzi L, Marangolo M. Psychological stress symptoms before and after autologous bone marrow transplantation in patients with solid tumors. Bone Marrow Transplant. 1996;17(5):843-847.
11. Fife B, Huster G, Cornetta K, Kennedy V, Akard L, Broun E. Longitudinal study of adaptation to the stress of bone marrow transplantation. J Clin Oncol. 2000;18(7):1539-1549.
12. Zittoun R, Achard S, Ruszniewski M. Assessment of quality of life during intensive chemotherapy or bone marrow transplantation. Psychooncology. 1999;8(1):64-73.
13. Carlson LE, Koski T, Gluck S. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer. Bone Marrow Transplant. 2001;27(9):989-998.
14. Larson PJ, Viele CS, Coleman S, Dibble SL, Cebulski C. Comparison of perceived symptoms of patients undergoing bone marrow transplant and the nurses caring for them. Oncol Nurs Forum. 1993;20(1):81-87.
15. Lawrence C, Gilbert C, Peters W. Evaluation of symptom distress in a bone marrow transplant outpatient environment. Ann Pharmacotherapy. 1996;30(9):941-945.
16. Molassiotis A, Van Den Akker OB, Milligan DW, Goldman JM, Boughton B. Psychological adaptation and symptom distress in bone marrow transplant recipients. Psychooncology. 1996;5:9-22.
17. Dodd M, Janson S, Facione N, et al. Advancing the science of symptom management. J Adv Nurs. 2001;33(5):668-676.
18. Leventhal H, Johnson J. Laboratory and field experimentation: development of a theory of self-regulation. In: Wooldridge PJ, Schmitt MH, Skipper JK, Leonard RC, ed. Behavioral Science and Nursing Theory. St Louis: Mosby; 1983:189-212.
19. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978;1(5):373-378.
20. Rhodes V, Watson P. Symptom distress - the concept: past and present. Semin Oncol Nurs. 1987;3(4):242-247.
21. Rhodes VA, McDaniel RW, Homan SS, Johnson M, Madsen R. An instrument to measure symptom experience. Symptom occurrence and symptom distress. Cancer Nurs. 2000;23(1):49-54.
22. McClement SE, Woodgate RL, Degner L. Symptom distress in adult patients with cancer. Cancer Nurs. 1997;20(4):236-243.
23. Tishelman C, Degner LF, Mueller B. Measuring symptom distress in patients with lung cancer. A pilot study of experienced intensity and importance of symptoms. Cancer Nurs. 2000;23(2):82-90.
24. Tishelman C, Taube A, Sachs L. Self-reported symptom distress in cancer patients: reflections of disease, illness or sickness? Soc Sci Med. 1991;33(11):1229-1240.
25. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634-1646.
26. Samarel N, Leddy SK, Greco K, et al. Development and testing of the symptom experience scale. J Pain Symptom Management. 1996;12(4):221-228.
27. Chang VT, Hwang SS, Fetterman M, Kasimis BS. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer. 2000;88(5):1175-1183.
28. Larsen J, Nordström G, Björkstrand B, Ljungman P, Gardulf A. Symptom distress, functional status and health-related quality of life prior to high-dose chemotherapy with stem-cell transplantation. Eur J Cancer Care. 2003;12:71-80.
29. Edman L, Larsen J, Hägglund H, Gardulf A. Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation. Eur J Cancer Care. 2001;10(2): 124-130.
30. Gottberg K, Gardulf A, Fredrikson S. Interferon-beta treatment for patients with multiple sclerosis: the patients' perceptions of the side-effects. Mult Scler. 2000;6(5):349-354.
31. Merup M, Åberg W, Löfvenberg E, et al. Symptom, symptom distress and health-related quality of life in patients with polycythemia vera or essential trombocythemia during treatment with interferon-alpha. Acta Oncol. 2002;41(1):50-55.
32. McCorkle R. The measurement of symptom distress. Semin Oncol Nurs. 1987;3(4):248-256.
33. Watson PM, Rhodes VA, Germino BB. Symptom distress: future perspectives for practice, education, and research. Semin Oncol Nurs. 1987;3(1):313-315.
34. Jenkins PL, Linington A, Whittaker JA. A retrospective study of psychosocial morbidity in bone marrow transplant recipients. Psychosomatics. 1991;32(1):65-71.
35. Baker F, Wingard JR, Curbow B, et al. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant. 1994;13(5): 589-596.
36. Ferrell BR, Grant MM. Quality of life and symptoms. In: King CR, Hinds PS, eds. Quality of Life. From Nursing and Patient Perspectives. Sudbury: Jones & Bartlett Publishers. 1998:140-156.